Additionally, we analyzed the co-occurrence of PTPN11 mutations with NPM1 and DNMT3A mutations, as well as the impact of M5 subtype on the prognosis of patients with PTPN11 mutations in adult AML. This evidence concerns the gene NPM1 and acute myeloid leukemia.